Merck & Co., Inc. Proceeds from (Repayments of) Short-term Debt
Merck & Co., Inc. (MRK) reported Proceeds from (Repayments of) Short-term Debt of $1.06 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2026-05-04
- Merck & Co., Inc. proceeds from (repayments of) short-term debt for the quarter ending 2026-03-31 was $1.06B.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt for the quarter ending 2025-09-30 was $15.00M.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt for the quarter ending 2025-06-30 was $48.00M.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt for the quarter ending 2025-03-31 was $0.00.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt for fiscal 2022 was $0.00.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt for fiscal 2021 was -$3.99B, a 256.38% decline from fiscal 2020.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt for fiscal 2020 was $2.55B.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt for fiscal 2019 was -$3.71B, a 172.40% decline from fiscal 2018.
| Period end | Proceeds from (Repayments of) Short-term Debt 3 month | Proceeds from (Repayments of) Short-term Debt 6 month | Proceeds from (Repayments of) Short-term Debt 9 month | Proceeds from (Repayments of) Short-term Debt 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.06B 10-Q · filed 2026-05-04 | |||
| 2025-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $63.00M derived: sum of 2 quarters · filed 2025-11-05 | $63.00M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $48.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $48.00M 10-Q · filed 2025-08-05 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-05 | |||
| 2023-06-30 | $1.94B 10-Q · filed 2024-08-05 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 derived: sum of 3 quarters · filed 2023-08-07 | $0.00 10-K · filed 2023-02-24 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-08-07 | $0.00 10-Q · filed 2022-11-03 | -$3.00M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | -$3.00M derived: sum of 3 quarters · filed 2023-08-07 | -$3.00M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | -$3.00M derived: sum of 2 quarters · filed 2023-02-24 | -$3.00M derived: sum of 3 quarters · filed 2023-02-24 | -$4.77B derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$3.00M derived: sum of 2 quarters · filed 2023-02-24 | -$4.77B derived: sum of 3 quarters · filed 2023-02-24 | -$3.99B 10-K · filed 2023-02-24 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$4.77B derived: sum of 2 quarters · filed 2022-11-03 | -$3.98B 10-Q · filed 2022-11-03 | -$1.12B derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | -$4.77B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$3.98B 10-Q · filed 2022-08-05 | -$1.12B derived: sum of 3 quarters · filed 2023-02-24 | -$3.40B derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $788.00M 10-Q · filed 2022-05-05 | $3.65B derived: sum of 2 quarters · filed 2023-02-24 | $1.37B derived: sum of 3 quarters · filed 2023-02-24 | -$246.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $2.86B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $582.00M derived: sum of 2 quarters · filed 2023-02-24 | -$1.03B derived: sum of 3 quarters · filed 2023-02-24 | $2.55B 10-K · filed 2023-02-24 |
| 2020-09-30 | -$2.28B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$3.89B derived: sum of 2 quarters · filed 2021-11-05 | -$311.00M 10-Q · filed 2021-11-05 | -$129.00M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$1.62B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.97B 10-Q · filed 2021-08-09 | $2.15B derived: sum of 3 quarters · filed 2022-02-25 | $1.79B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $3.58B 10-Q · filed 2021-05-05 | $3.77B derived: sum of 2 quarters · filed 2022-02-25 | $3.40B derived: sum of 3 quarters · filed 2022-02-25 | $4.01B derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $182.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$178.00M derived: sum of 2 quarters · filed 2022-02-25 | $425.00M derived: sum of 3 quarters · filed 2022-02-25 | -$3.71B 10-K · filed 2022-02-25 |
| 2019-09-30 | -$360.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $243.00M derived: sum of 2 quarters · filed 2020-11-05 | -$3.89B 10-Q · filed 2020-11-05 | -$1.06B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $603.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$3.53B 10-Q · filed 2020-08-05 | -$702.00M derived: sum of 3 quarters · filed 2021-02-25 | -$477.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$4.13B 10-Q · filed 2020-05-06 | -$1.30B derived: sum of 2 quarters · filed 2021-02-25 | -$1.08B derived: sum of 3 quarters · filed 2021-02-25 | $990.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $2.83B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.06B derived: sum of 2 quarters · filed 2021-02-25 | $5.13B derived: sum of 3 quarters · filed 2021-02-25 | $5.12B 10-K · filed 2021-02-25 |
| 2018-09-30 | $225.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.29B derived: sum of 2 quarters · filed 2019-11-05 | $2.29B 10-Q · filed 2019-11-05 | $306.00M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $2.07B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.07B 10-Q · filed 2019-08-06 | $81.00M derived: sum of 3 quarters · filed 2020-02-26 | $2.07B derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | -$1.00M 10-Q · filed 2019-05-08 | -$1.99B derived: sum of 2 quarters · filed 2020-02-26 | -$3.00M derived: sum of 3 quarters · filed 2020-02-26 | -$3.81B derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | -$1.99B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$2.00M derived: sum of 2 quarters · filed 2020-02-26 | -$3.81B derived: sum of 3 quarters · filed 2020-02-26 | -$26.00M 10-K · filed 2020-02-26 |
| 2017-09-30 | $1.99B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$1.82B derived: sum of 2 quarters · filed 2018-11-06 | $1.96B 10-Q · filed 2018-11-06 | $1.05B derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$3.81B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$24.00M 10-Q · filed 2018-08-07 | -$933.00M derived: sum of 3 quarters · filed 2019-02-27 | -$15.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $3.78B 10-Q · filed 2018-05-08 | $2.88B derived: sum of 2 quarters · filed 2019-02-27 | $3.79B derived: sum of 3 quarters · filed 2019-02-27 | $3.78B derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$909.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $9.00M derived: sum of 2 quarters · filed 2019-02-27 | $0.00 derived: sum of 3 quarters · filed 2019-02-27 | $0.00 10-K · filed 2019-02-27 |
| 2016-09-30 | $918.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $909.00M derived: sum of 2 quarters · filed 2017-11-07 | $909.00M 10-Q · filed 2017-11-07 | $895.00M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$9.00M 10-Q · filed 2017-08-08 | -$23.00M derived: sum of 3 quarters · filed 2018-02-27 | -$20.00M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | -$14.00M derived: sum of 2 quarters · filed 2018-02-27 | -$11.00M derived: sum of 3 quarters · filed 2018-02-27 | -$3.72B derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$11.00M derived: sum of 2 quarters · filed 2018-02-27 | -$3.72B derived: sum of 3 quarters · filed 2018-02-27 | -$1.54B 10-K · filed 2018-02-27 |
| 2015-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$3.70B derived: sum of 2 quarters · filed 2016-11-07 | -$1.53B 10-Q · filed 2016-11-07 | -$5.06B derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | -$3.71B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$1.53B 10-Q · filed 2016-08-08 | -$5.07B derived: sum of 3 quarters · filed 2017-02-28 | -$103.00M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $2.18B 10-Q · filed 2016-05-09 | -$1.36B derived: sum of 2 quarters · filed 2017-02-28 | $3.60B derived: sum of 3 quarters · filed 2017-02-28 | -$1.43B derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$3.54B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $1.43B derived: sum of 2 quarters · filed 2017-02-28 | -$3.61B derived: sum of 3 quarters · filed 2017-02-28 | -$460.00M 10-K · filed 2017-02-28 |
| 2014-09-30 | $4.96B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$72.00M derived: sum of 2 quarters · filed 2015-11-05 | $3.08B 10-Q · filed 2015-11-05 | $2.77B derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | -$5.04B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$1.89B 10-Q · filed 2015-08-06 | -$2.20B derived: sum of 3 quarters · filed 2016-02-26 | -$3.75B derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $3.15B 10-Q · filed 2015-05-07 | $2.84B derived: sum of 2 quarters · filed 2016-02-26 | $1.29B derived: sum of 3 quarters · filed 2016-02-26 | $2.11B derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | -$310.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$1.86B derived: sum of 2 quarters · filed 2016-02-26 | -$1.04B derived: sum of 3 quarters · filed 2016-02-26 | -$159.00M 10-K · filed 2016-02-26 |
| 2013-09-30 | -$1.55B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$729.00M derived: sum of 2 quarters · filed 2014-11-10 | $151.00M 10-Q · filed 2014-11-10 | $1.05B derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $822.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.70B 10-Q · filed 2014-08-07 | $2.61B derived: sum of 3 quarters · filed 2015-02-27 | $689.00M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $880.00M 10-Q · filed 2014-05-08 | $1.78B derived: sum of 2 quarters · filed 2015-02-27 | -$133.00M derived: sum of 3 quarters · filed 2015-02-27 | $870.00M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $904.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$1.01B derived: sum of 2 quarters · filed 2015-02-27 | -$10.00M derived: sum of 3 quarters · filed 2015-02-27 | $624.00M 10-K · filed 2015-02-27 |
| 2012-09-30 | -$1.92B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$914.00M derived: sum of 2 quarters · filed 2013-11-07 | -$280.00M 10-Q · filed 2013-11-07 | -$560.00M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $1.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $1.64B 10-Q · filed 2013-08-07 | $1.36B derived: sum of 3 quarters · filed 2014-02-27 | $1.32B derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $634.00M 10-Q · filed 2013-05-09 | $354.00M derived: sum of 2 quarters · filed 2014-02-27 | $314.00M derived: sum of 3 quarters · filed 2014-02-27 | $1.91B derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | -$280.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$320.00M derived: sum of 2 quarters · filed 2014-02-27 | $1.27B derived: sum of 3 quarters · filed 2014-02-27 | $1.08B 10-K · filed 2014-02-27 |
| 2011-09-30 | -$40.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.55B derived: sum of 2 quarters · filed 2012-11-09 | $1.36B 10-Q · filed 2012-11-09 | -$127.00M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $1.59B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $1.40B 10-Q · filed 2012-08-07 | -$87.00M derived: sum of 3 quarters · filed 2013-02-28 | -$172.00M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | -$197.00M 10-Q · filed 2012-05-08 | -$1.68B derived: sum of 2 quarters · filed 2013-02-28 | -$1.76B derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | -$1.48B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$1.57B derived: sum of 2 quarters · filed 2013-02-28 | $90.00M 10-K · filed 2013-02-28 | |
| 2010-09-30 | -$85.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $1.57B 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $1.66B 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | -$2.30B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$2.41B derived: sum of 2 quarters · filed 2012-02-28 | -$2.42B 10-K · filed 2012-02-28 | |
| 2009-09-30 | -$114.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | -$122.00M 10-Q · filed 2009-10-29 | ||
| 2009-06-30 | -$8.00M 10-Q · filed 2009-07-24 | |||
| 2008-09-30 | -$167.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | -$207.00M 10-Q · filed 2009-10-29 | ||
| 2008-06-30 | -$40.00M 10-Q · filed 2009-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |